Valuation: Medpace Holdings, Inc.

Capitalization 17.08B 14.52B 13.46B 12.58B 23.45B 1,569B 24.86B 154B 61.08B 741B 64.04B 62.73B 2,695B P/E ratio 2025 *
41x
P/E ratio 2026 * 36.8x
Enterprise value 16.67B 14.18B 13.14B 12.28B 22.9B 1,532B 24.27B 150B 59.64B 723B 62.52B 61.24B 2,631B EV / Sales 2025 *
6.64x
EV / Sales 2026 * 5.69x
Free-Float
83.69%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.01%
1 week-3.74%
Current month+4.70%
1 month+3.22%
3 months-1.43%
6 months+34.44%
Current year+4.70%
More quotes
1 week 579.03
Extreme 579.029
624
1 month 551
Extreme 551
628.92
Current year 551
Extreme 551
628.92
1 year 250.05
Extreme 250.05
628.92
3 years 167
Extreme 167
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
More quotes
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
President 51 2021-07-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.01%-3.74%+69.03%+145.51% 17.08B
+0.04%-1.56%-4.31%+14.75% 49.33B
-1.56%-1.00%+14.23%+2.87% 40.71B
+0.15%+0.33%+52.68%+26.14% 37.49B
+1.92%+0.71%+22.15%+42.46% 31.07B
-0.99%-2.20%+185.93%+328.06% 22.97B
-0.90%-2.40%+46.36%+10.78% 14.81B
Average -0.98%-0.96%+55.15%+81.51% 30.49B
Weighted average by Cap. -0.98%-0.78%+42.94%+62.42%
See all sector performances

Financials

2025 *2026 *
Net sales 2.51B 2.14B 1.98B 1.85B 3.45B 231B 3.66B 22.62B 8.98B 109B 9.42B 9.22B 396B 2.81B 2.39B 2.22B 2.07B 3.86B 258B 4.09B 25.35B 10.06B 122B 10.55B 10.33B 444B
Net income 436M 371M 344M 321M 599M 40.07B 635M 3.93B 1.56B 18.92B 1.64B 1.6B 68.82B 479M 408M 378M 353M 658M 44.05B 698M 4.32B 1.71B 20.8B 1.8B 1.76B 75.66B
Net Debt -404M -344M -319M -298M -555M -37.13B -588M -3.64B -1.45B -17.53B -1.52B -1.48B -63.77B -1.06B -902M -836M -781M -1.46B -97.46B -1.54B -9.56B -3.79B -46.02B -3.98B -3.9B -167B
More financial data * Estimated data
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Employees
6,200
More about the company
Date Price Change Volume
26-01-23 588.05 $ -3.01% 301,634
26-01-22 606.27 $ -2.31% 182,885
26-01-21 620.59 $ +3.02% 251,248
26-01-20 602.40 $ -1.39% 207,156
26-01-16 610.90 $ -1.16% 232,679

Delayed Quote Nasdaq, January 23, 2026 at 04:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
606.27USD
Average target price
545.75USD
Spread / Average Target
-9.98%
Consensus

Quarterly revenue - Rate of surprise